questionText: To ask the Secretary of State for Health and Social Care, whether he has considered the potential merits of taking steps to help prevent the withdrawal of medical (a) products and (b) treatments for rare conditions from the UK market where that withdrawal
answerText: Companies may decide to stop manufacturing a medicine for several reasons including commercial decisions, manufacturing capacity restraint and production problems. Companies are free to review their portfolios as they think necessary, and the Department h...
heading: Rare Diseases: Medical Treatments